Greystone Associates
Analyzes Factors Driving Continuous Cardiac Monitoring
(Amherst,
NH) – As
new-generation cardiac devices and monitoring products converge with
wireless networks, medical professionals are acquiring the capability to
monitor key patient parameters and implanted device data in near-real
time. These new communication-enabled wireless heart devices function like On-Stars for
humans, sending data on a timed or exception basis. The recent FDA
approval of three cardiovascular implants signal the arrival of a new
phase in the marriage of electronics and medical devices - one in which
critical patient data can be used be caregivers to modify treatment
protocols or schedule interventional procedures in response to current
patient status regardless of the patient's location. Products in this
sector also include ambulatory vital signs monitors that are designed to
send heart rate, BP and related data over a wide area network.
Successful development
and commercialization of wireless heart devices requires strong working
partnerships and cooperation between and among device developers, wireless
providers, and regulators. As these wireless-enabled devices grow and
penetrate the population of cardiovascular patients - a population which
itself is expected to grow - the importance of service centers,
specialized service bureaus that function by relaying device data to the
appropriate respondent on an exception basis, will increase in importance.
Emerging wireless heart monitoring data platforms - proprietary sensor-enabled systems that
allow physiological data to be retrieved via a number of wireless
technologies - will also impact this market segment.
These findings are
contained in a new and comprehensive report. The report -Remote
Cardiovascular Care - contains in-depth analysis of the devices,
technology, and market participants that are shaping the future of
ambulatory cardiovascular medicine.
Source: Greystone Associates
|